Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
暂无分享,去创建一个
Bin Wang | Jing Liu | Yi Zhang | Hui Yang | Kun-Liang Guan | Ping Wang | Wei Xu | Stephen Frye | Se-Hee Kim | Yue Xiong | Bin Wang | S. Frye | Y. Xiong | K. Guan | ping wang | Shimin Zhao | Ying Liu | Hui Yang | Shinsuke Ito | Q. Lei | Jinye Zhang | Li-xia Liu | Mengtao Xiao | Pu Wang | Ying Yang | W. Xu | Se-Hee Kim | Chen Yang | Wenyuan Jiang | Jing Liu | Yi Zhang | Yanhui Xu | Ying Yang | Shinsuke Ito | Ying Liu | Chen Yang | Pu Wang | Meng-Tao Xiao | Li-xia Liu | Wen-qing Jiang | Jin-ye Zhang | Yan-hui Xu | Qun-ying Lei | Shi-min Zhao | Lixia Liu
[1] M. Aghili,et al. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review , 2008, Journal of Neuro-Oncology.
[2] Eyal Gottlieb,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[3] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[4] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[5] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[6] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[7] F. Ducray,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[8] M. Ivan,et al. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.
[9] Patricia A. Ortiz-Tello,et al. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase , 2007, Nature Structural &Molecular Biology.
[10] H. Erdjument-Bromage,et al. Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.
[11] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[12] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[13] F. Ducray,et al. Diagnostic and prognostic markers in gliomas , 2009, Current opinion in oncology.
[14] D. Peet,et al. The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. , 2010, Cell metabolism.
[15] Y. Hayashi,et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). , 2002, Cancer research.
[16] S. Krane,et al. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens , 2008, Amino Acids.
[17] David R. Liu,et al. Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .
[18] M. Biel,et al. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. , 2010, Angewandte Chemie.
[19] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[20] C. Cunliffe,et al. Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives. , 1992, Journal of medicinal chemistry.
[21] Xiaobo Xia,et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.
[22] Yuen-Li Chung,et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.
[23] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[24] Ken Chen,et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.
[25] Paul Tempst,et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. , 2007, Molecular cell.
[26] J. Licht,et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.
[27] G. Semenza,et al. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .
[28] Jianping Ding,et al. Molecular mechanisms of “off-on switch” of activities of human IDH1 by tumor-associated mutation R132H , 2010, Cell Research.
[29] R. Rzem,et al. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Soulier,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[31] S. Meier-Ewert,et al. A Novel Gene (PLU-1) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer* , 1999, The Journal of Biological Chemistry.
[32] L. Aravind,et al. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids , 2009, Cell cycle.
[33] S. McKnight,et al. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.
[34] Yi Zhang,et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.
[35] A. Hagemeijer,et al. Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.
[36] Omar Abdel-Wahab,et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.
[37] R. Hausinger,et al. Fe(II)/alpha-ketoglutarate hydroxylases involved in nucleobase, nucleoside, nucleotide, and chromatin metabolism. , 2008, Dalton transactions.
[38] C. Schofield,et al. Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins. , 2006, Journal of inorganic biochemistry.
[39] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[40] A. Paetau,et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.
[41] R. Janknecht,et al. Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma , 2007 .
[42] Christopher J Schofield,et al. Expanding chemical biology of 2-oxoglutarate oxygenases. , 2008, Nature chemical biology.
[43] R. Dowell,et al. Novel inhibitors of prolyl 4-hydroxylase. , 1992, Journal of medicinal chemistry.
[44] Kun-Liang Guan,et al. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.
[45] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[46] Yuan Qi,et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak , 2010 .
[47] P. Kleihues,et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. , 2009, The American journal of pathology.
[48] N. Heintz,et al. The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.
[49] M. Simpson,et al. Structural Insights into Histone Demethylation by JMJD2 Family Members , 2006, Cell.
[50] Tak W. Mak,et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations , 2010, The Journal of experimental medicine.
[51] S. Mathew,et al. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23) , 2003, Leukemia.
[52] C. Chen,et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer , 2007, Proceedings of the National Academy of Sciences.
[53] M. Lathrop,et al. L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. , 2004, Human molecular genetics.
[54] D. Peet,et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.
[55] R. Janknecht,et al. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. , 2007, Human molecular genetics.